Partner Hospitals

Founded in 1892, it is China’s first medical institution certified as an International Comprehensive Stroke Center by the World Stroke Organization. Specialties including rheumatology and immunology, orthopedics, obstetrics and gynecology, endocrinology and neurology rank among the top in China. It has established friendly ties with more than 20 international partner hospitals across 13 countries on five continents. Luoyang Orthopedic Hospital of Henan Province

Founded in 1869, the hospital has set national benchmarks including the “Hangzhou Protocol” for transcatheter heart valve replacement, minimally invasive complex cataract surgery, standardized diagnosis and treatment of colorectal tumors, and mass severe trauma rescue. The perioperative survival rate of pediatric liver transplantation is at the internationally leading level.

Founded in 1947, it enjoys a high reputation in organ transplantation, infectious diseases, hematological diseases, kidney diseases, urinary system diseases and clinical pharmacy. It is one of China’s medical centers with the most complete range of large organ transplantation procedures.

Founded in 1920. It is the supporting institution for the National Center for Stomatology and the National Clinical Research Center for Oral Diseases. Its Department of Plastic and Reconstructive Surgery remains the world’s largest plastic surgery medical center and China’s leading center for plastic surgery in medical treatment, teaching and research. Annual outpatient and emergency visits exceed 4.8 million, inpatient admissions over 150,000, inpatient surgeries more than 90,000, and outpatient surgical procedures over 170,000.

Founded in 1957, it is China’s first Grade A tertiary specialized hospital focusing on the diagnosis and treatment of cardiothoracic diseases after the founding of the People’s Republic of China. Centered on two major discipline clusters: thoracic tumors and cardiovascular diseases, it masters the most extensive spectrum and full range of diagnostic and therapeutic technologies for cardiothoracic diseases in China. Annual outpatient and emergency visits exceed 860,000, with more than 28,000 surgeries performed each year. The proportion of Grade-III and Grade-IV surgeries is over 90%. Its surgical volume for tracheal and mediastinal tumors ranks No.1 nationwide, lung tumor surgery volume ranks No.2 nationwide, and esophageal surgery volume is among the top in China and ranks No.1 in the city.

Founded in 1904. The hospital registers more than 5.3 million annual outpatient and emergency visits, over 180,000 annual inpatient admissions, and more than 120,000 annual inpatient operations. The leading specialties including Orthopedics and Endocrinology and Metabolism enjoy nationally top-tier medical capabilities. The cure rates for complex trauma, hand and foot microsurgery, and refractory endocrine diseases rank among the highest in China.

Founded in 1931. It is equipped with 22 high-end medical devices including Da Vinci surgical robots, MR Linac, TOMO, LA, PET-CT, PET-MR and 5.0T MRI. Annual outpatient visits: 2.5 million; annual inpatient admissions: 170,000; annual surgeries: 80,000; annual radiotherapy sessions: 420,000. The overall 5-year survival rate of patients with malignant tumors reaches 72%.

Founded in 1907, the hospital has an annual total of over 6 million outpatient and emergency visits, nearly 200,000 inpatient admissions and more than 100,000 surgeries. As Shanghai’s first medical institution offering foreign-related medical services, it is a designated medical facility for consulates of 10 countries. It has served more than 600,000 foreign patients from over 100 countries and regions worldwide.